{"id":269944,"date":"2026-09-25T10:09:42","date_gmt":"2026-09-25T04:39:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=269944"},"modified":"2026-09-25T10:09:42","modified_gmt":"2026-09-25T04:39:42","slug":"fdc-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/fdc-best-stock-in-its-sector\/","title":{"rendered":"Is FDC the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

FDC CMP Rs 345 (25 Sep 2026). Market cap Rs 5,627 Cr. ROE 11.32%. P\/E 19.23x versus Industry P\/E 38.64x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

FDC is one of the names investors compare when screening the Healthcare sector, built on a 11.32% return on equity and a P\/E of 19.23x against an Industry P\/E of 38.64x. Whether FDC is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is FDC<\/a> the best stock in its sector? The stock trades on the NSE at Rs 345 as of 25 September 2026, within its 52-week range of Rs 312.95 to Rs 484.40. FDC Ltd manufactures pharmaceutical formulations across multiple therapeutic segments.<\/p>\n

FDC sits in the Healthcare sector, and its 11.32% ROE and 19.23x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n